Walden Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Walden Wealth Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$728K	Hold	7,500	–	–	0.41%	39
2024 Q1	$656K	Hold	7,500	–	–	0.38%	40
2023 Q4	$598K	Buy	+7,500	New	+$564K	0.38%	41

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Walden Wealth Partners's CL Position: Q2 2024 in Review

Walden Wealth Partners held its Colgate-Palmolive (CL) position steady in Q2 2024 at 7,500 shares worth $728K. The position accounts for 0.41% of the portfolio, ranked #39.

Walden Wealth Partners first reported a position in CL in Q4 2023 and has held it in 3 quarters since. 1,819 funds tracked by Wall St. Rank hold CL as of Q2 2024.

Walden Wealth Partners held 7,500 shares of Colgate-Palmolive worth $728K as of Q2 2024.
Walden Wealth Partners left its Colgate-Palmolive share count unchanged in Q2 2024.
Colgate-Palmolive made up 0.41% of Walden Wealth Partners's portfolio in Q2 2024, its #39 holding.
Walden Wealth Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 3 quarters since.
1,819 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Walden Wealth Partners's 13F filing for Q2 2024, filed 11 Jul 2024.